Lv4
600 积分 2024-04-13 加入
ctDNA dynamics and recurrence patterns after organ-sparing trimodality therapy for bladder cancer
7个月前
已完结
Changes in circulating tumor cells (CTCs) and HER2 expression in evaluating the efficacy of neoadjuvant disitamab vedotin plus toripalimab treatment in patients with muscle-invasive bladder cancer (MIBC)
10个月前
已完结
Neoadjuvant Chemotherapy with Transurethral Resection for Bladder Preservation: 15-year follow-up of the retained bladder
1年前
已关闭
皖公网安备34019202002308
